Anna Dejana
- Hematology top 5%
- Genetics top 5%
- Rheumatology top 10%
- Molecular Biology
- Public Health, Environmental and Occupational Health
- Co-authors
- Mario SessaregoEnrica LermaFrancesco FrassoniAngelo Michele CarellaGiuseppina FugazzaM. ValbonesiFederica BenvenutoMarina Podestà
- Topics
- Chronic Myeloid Leukemia Treatments (18 papers)Acute Myeloid Leukemia Research (9 papers)Chronic Lymphocytic Leukemia Research (7 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Anna Dejana
22 papers receiving 401 citations
Peers
Comparison fields: 5 of 47
- Hematology 348
- Genetics 219
- Rheumatology 98
- Molecular Biology 64
- Public Health, Environmental and Occupational Health 63
Countries citing papers authored by Anna Dejana
This map shows the geographic impact of Anna Dejana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dejana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dejana more than expected).
Fields of papers citing papers by Anna Dejana
This network shows the impact of papers produced by Anna Dejana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dejana. The network helps show where Anna Dejana may publish in the future.
Co-authorship network of co-authors of Anna Dejana
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Dejana. A scholar is included among the top collaborators of Anna Dejana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Dejana. Anna Dejana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 30 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 13 | |
| 7 | 5 | |
| 8 | 51 | |
| 9 | 13 | |
| 10 | 24 | |
| 11 | 46 | |
| 12 | 5 | |
| 13 | High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. | 19 |
| 14 | 53 | |
| 15 | 9 | |
| 16 | Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia. | 1 |
| 17 | 12 | |
| 18 | 18 | |
| 19 | 9 | |
| 20 | 50 |
About Anna Dejana
Anna Dejana is a scholar working on Hematology, Genetics and Rheumatology, having authored 22 papers that have together received 425 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (18 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Hematology (348 citations), Genetics (219 citations) and Rheumatology (98 citations). Anna Dejana has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Mario Sessarego, Enrica Lerma, Francesco Frassoni, Angelo Michele Carella, Giuseppina Fugazza, M. Valbonesi, Federica Benvenuto, Marina Podestà, Raffaella Defferrari and Maria Teresa Corsetti. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.